Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples